REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 65 filers reported holding REPARE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $325,798 | +10.3% | 26,970 | -3.4% | 0.00% | – |
| Q2 2023 | $295,404 | +35.1% | 27,921 | +25.6% | 0.00% | – |
| Q1 2023 | $218,674 | -30.2% | 22,223 | +4.4% | 0.00% | – |
| Q4 2022 | $313,220 | +78.0% | 21,293 | +47.7% | 0.00% | – |
| Q3 2022 | $176,000 | -12.9% | 14,420 | +0.1% | 0.00% | – |
| Q2 2022 | $202,000 | +15.4% | 14,412 | +18.0% | 0.00% | – |
| Q1 2022 | $175,000 | -12.9% | 12,209 | +89.2% | 0.00% | – |
| Q2 2021 | $201,000 | -23.0% | 6,454 | -24.2% | 0.00% | – |
| Q1 2021 | $261,000 | – | 8,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,539,644 | $79,186,000 | 18.42% |
| MPM ASSET MANAGEMENT LLC | 2,271,177 | $70,815,000 | 13.16% |
| MPM BioImpact LLC | 1,676,087 | $52,260,000 | 8.58% |
| BVF INC/IL | 3,722,398 | $116,064,000 | 4.35% |
| GREAT POINT PARTNERS LLC | 436,089 | $13,597,000 | 2.85% |
| Redmile Group, LLC | 2,624,396 | $81,829,000 | 1.21% |
| Orbimed Advisors | 3,426,325 | $106,833,000 | 1.08% |
| SECTORAL ASSET MANAGEMENT INC | 412,150 | $12,851,000 | 1.04% |
| Logos Global Management LP | 330,000 | $10,289,000 | 0.86% |
| CLOUGH CAPITAL PARTNERS L P | 348,279 | $10,859,000 | 0.59% |